To identify the current status of scientific knowledge in fructo-oligosaccharides (FOS), non-conventional sugars that play an important role in glycemia control.
Introduction
Different from the majority of simple sugars and oligosaccharides, fructo-oligosaccharide (FOS), a naturally occurring oligosaccharide, passes intact through the upper digestive tract without being digested but is degraded in the colon by indigenous bacteria 1 . FOS are mainly known for its ability to improve host health as it stimulates the growth of some beneficial bacteria, such as the bifidobacteria.FOS may be found in many plant foods such as bananas, onions, garlic, asparagus, wheat, rye, Jerusalem artichoke. Besides, it may be produced enzymatically 6 .
It is possible to find industrial products containing FOS, alone or with other ingredients in Brazil. Recent use of FOS as a food ingredient has stimulated much research to know its functionality and its effects on human health, especially in relation to its bifidogenic character 7 . Thus, its potentially beneficial effects in preventing and controlling some diseases have been extensively discussed, particularly in those conditions associated with the increase of peripheral insulin resistance, eg, diabetes mellitus and metabolic syndrome.Recent studies suggest that butyrate and other short-chain fatty acids (SCFA) may mediate the effects of diet and gut microbiota on host appetite, metabolism, adiposity, and immunity [8] [9] [10] [11] .
Considering that non digestible oligosaccharides are often cited as being important dietary fibers in nutritional advice concerning specific disorders associated with the metabolic syndrome 12 , the aim of this review was to know the current status of FOS specific role in blood glucose control.
Methods
We conducted a search for scientific articles in MEDLINE 
Results

Metabolism of FOS
FOS are not hydrolyzed by endogenous enzymes in the small intestine of humans and following ingestion reach the cecum and colon in intact form, where they are metabolized completely by the colonic microflora, through fermentation, producing gases (carbon dioxide, hydrogen, methane) and reducing the colon pH by lactate and SCFA production, such as acetate, propionate and butyrate, which are quickly absorbed by the colonic mucosa [13] [14] [15] [16] [17] .
The solubility of these oligosaccharides in water decreases fecal content and increases intestinal transit time Butyrate, together with acetate and propionate, are major SCFA, also known as volatile fatty acids, produced by microbial fermentation in the gastrointestinal tract 18 .
Digestive tolerance to FOS depends on the amount ingested, the presence of factors that reduce their osmotic load in the small intestine and the degree of adaptation of the colonic microflora in the fermentation of these sugars. The osmotic effect of these sugars is determined by the concentration of sugar that leaves the stomach and this obviously depends on the amount ingested, but also on factors that slow gastric emptying, the type of meal and its solid content and viscosity 16 . The fraction fermented in the large intestine provides 8.4 kJ / g (2 kcal) and energy loss when a sugar is fermented is approximately 50% 16 .
Experimental studies
Boillot et al. 19 showed that long-term dietary supplementation with propionate lowers blood glucose, suggesting that the improvement in glucose tolerance and insulin sensitivity may be due to propionate effects on carbohydrate metabolism. A study using Sprague-Dawley rats showed that these concentrations
were not affected by supplemental propionate, a short-chain fatty acid. However, it should be noted that the amount of propionate in this study was small (3g / kg), compared with the previous study, where twenty-fold larger doses were used 20 . Although it is known that high levels of free fatty acids (FFA) are associated with insensitivity to insulin and inhibition of glucose uptake by muscle 21 , some studies have found that lower FFA levels were not associated with a reduction in blood glucose, although in fasting, such levels have shown a tendency to lower values in the group fed with propionate but no significant difference between groups 19 .
Propionate has some hypoglycemic effect under certain circumstances 22 . The mechanism of action of propionate at cellular level in isolated rat hepatocytes 23 is related to a decrease in gluconeogenesis 24 , inhibition of pyruvate carboxylase, which in turn is inhibited by metabolic products of propionate, the methylmalonyl-CoA and succinyl CoA 25 . In addition, propionate stimulates glycolysis in isolated rat hepatocytes 24 although shown to be gluconeogenic in vitro 23 .
Fructo-oligosaccharide effects on blood glucose. An overview Clinical studies
Yamashita et al. 26 studied the systemic effects of adding FOS (8g daily) for 14 days to the diet of patients with type 2 diabetes mellitus whose serum glucose concentration was uncontrolled. Fasting blood test showed an 8% reduction in serum glucose levels 26 . Alles et al. 6 used 15g for 20 days in patients with type 2 diabetes and found no significant changes in glucose levels.
In another study, Luo et al. 27 showed that chronic consumption of 20 g FOS / day in healthy individuals decreased the hepatic glucose production but had no effect on glucose metabolism stimulated by insulin. Similar results were found by other researchers 28, 29 Acetate can reduce plasma free fatty acids (FFA) 33 and this could benefit the blood glucose and insulin sensitivity in the long term because high concentrations of fatty acids decrease tissue glucose utilization and increase tissue insulin resistance 21 .Unlike sucrose, 25g of FOS did not increase serum levels of postprandial glucose and fructose 16 . The improvement in carbohydrate metabolism could be justified by the SCFA, since propionate and / or acetate administered intravenously, orally or by rectal infusion reduces plasma FFA concentrations 34, 35 . For Cummings 36 , SCFA absorbed in the colon can improve carbohydrate metabolism, considering that a high concentration of sodium propionate in the diet is associated with a noticeable improvement in carbohydrate tolerance due to inhibition of salivary amylase. Other studies where viscous fiber meals and low glycemic index foods 37, 38 replaced the normal diet in healthy volunteers 39 and in patients with diabetes 40, 41 also indicated a subsequent reduction in the concentrations of blood glucose and insulin. However, Giacco et al.
42
, using FOS 10.6 g /day of did not detect effects on blood glucose, either in fasting or in the postprandial period.Studies with infants indicate that consumption of prebiotic mixtures galactooligosaccharide / fructooligosaccharide and inulin/ galactooligosaccharide reduce the incidence of infections 43 .
These results are important, especially in the preparation of infant formula, although these studies are not conclusive with respect to diarrhea, especially in patients with chronic intestinal inflammation and those in treatment with antibiotics. In general, dietary fiber and FOS appear to have similar effects in children and adults.
Conclusions
This review demonstrates that consumption of FOS has a beneficial influence on glucose metabolism. The controversies verified here seem to be linked to inadequate methodological designs and/or the small number of individuals included in some studies. The use of FOS supplementation in the diet may therefore be a strategy for reducing blood glucose. The duration of the treatment and dose to be administered are still questions to be answered. Further studies may clarify these questionings.
